Ulcerative Colitis Diagnosis and Management

Key Diagnostic Features

The combination of chronic bloody diarrhea, bilateral lower abdominal pain, severe anemia, and association with axial spondyloarthropathy is highly suggestive of ulcerative colitis, according to the European Crohn’s and Colitis Organisation 1
Bilateral lower abdominal pain with bloody diarrhea represents the classic ulcerative colitis symptom complex, as noted by the European Society of Gastrointestinal Endoscopy 2
Progressive anemia with positive stool occult blood indicates chronic gastrointestinal blood loss from mucosal inflammation, a common feature of ulcerative colitis, as reported by the American Gastroenterological Association 2
Approximately 20% of ulcerative colitis patients develop peripheral or axial arthropathy, making this the second most common extraintestinal manifestation, according to the American College of Rheumatology 2
Patients with axial spondyloarthropathy have a significantly higher incidence and prevalence of inflammatory bowel disease compared to the general population, as noted by the Spondyloarthritis Research Consortium of Canada 1

Peptic ulcer disease typically causes epigastric pain, not bilateral lower abdominal pain, and does not explain the association with axial spondyloarthropathy, as reported by the American Gastroenterological Association 3
Infectious diarrhea rarely persists for 4 weeks without fever, and the chronic progressive nature with worsening anemia suggests chronic inflammatory disease rather than infection, according to the Infectious Diseases Society of America 3
C. difficile must still be excluded in all new presentations of diarrhea regardless of antibiotic history before confirming inflammatory bowel disease diagnosis, as recommended by the American College of Gastroenterology 6

Colonoscopy with biopsies from multiple sites is the gold standard and only definitive way to diagnose ulcerative colitis, according to the American Society for Gastrointestinal Endoscopy 6
Stool culture and C. difficile toxin testing must be obtained before confirming inflammatory bowel disease diagnosis, as recommended by the American Gastroenterological Association 6
Complete blood count, ESR or CRP, comprehensive metabolic panel, serum albumin, and ferritin can help assess disease severity and iron deficiency, as reported by the European Crohn’s and Colitis Organisation 6

Intravenous corticosteroids are first-line for severe ulcerative colitis, with consideration of TNF-alpha antibodies (infliximab or adalimumab, NOT etanercept) if steroid-refractory, according to the American Gastroenterological Association 1
NSAIDs should be discontinued immediately, as they can exacerbate inflammatory bowel disease and may have contributed to the current presentation, as recommended by the American College of Gastroenterology 6
The previous use of etanercept for spondyloarthropathy is relevant because etanercept lacks efficacy for ulcerative colitis, while other TNF inhibitors (infliximab, adalimumab) effectively treat both conditions, as noted by the European League Against Rheumatism 1